Does the efficacy of ruxolitinib for vitiligo vary across Fitzpatrick skin types?

Featuring Neal Bhatia, MD |

Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, CA

| Published March 03, 2025

Loading...

Related CME

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2025 dermsquared | All Rights Reserved